Disease burden of type 2 diabetes mellitus in China from 1990 to 2019

ZHOU Wuming; CUI Xuanxuan; LU Zongqing; HUA Tianfeng; ZHANG Jin; YANG Min

doi:10.16462/j.cnki.zhjbkz.2023.06.006

Volume 27 Issue 6

Jun. 2023

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2023 > 27(6): 650-654

ZHOU Wuming, CUI Xuanxuan, LU Zongqing, HUA Tianfeng, ZHANG Jin, YANG Min. Disease burden of type 2 diabetes mellitus in China from 1990 to 2019[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(6): 650-654. doi: 10.16462/j.cnki.zhjbkz.2023.06.006

Citation:

ZHOU Wuming, CUI Xuanxuan, LU Zongqing, HUA Tianfeng, ZHANG Jin, YANG Min. Disease burden of type 2 diabetes mellitus in China from 1990 to 2019[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(6): 650-654. doi: 10.16462/j.cnki.zhjbkz.2023.06.006

Citation:

PDF( 866 KB)

Disease burden of type 2 diabetes mellitus in China from 1990 to 2019

doi: 10.16462/j.cnki.zhjbkz.2023.06.006

Laboratory of Cardiopulmonary Resuscitation and Critical Care, The Second Affiliated Hospital of Anhui Medical University, Department of Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China

Funds:

National Natural Science Foundation of China 82072134

National Natural Science Foundation Youth Science Foundation 81601661

More Information

Corresponding author: YANG Min, E-mail: yangmin@ahmu.edu.cn
Received Date: 2022-08-03
Rev Recd Date: 2022-12-18

Available Online: 2023-07-10

Publish Date: 2023-06-10

Abstract

Abstract

Objective This study aims to evaluate the disease burden of type 2 diabetes mellitus(T2DM) in China from 1990 to 2019. Methods Data from the Global Burden of Disease Study 2019 data were employed to analyze the T2DM burden in China. Results In 2019, the rates of incidence, prevalence, mortality, disability adjusted life years (DALY), years of life lost (YLL), and years lived with disability (YLD) of T2DM in China were 262.88/100 000, 6 328.79/100 000, 11.84/100 000, 675.18/100 000, 234.65/100 000 and 440.52/100 000, respectively. These metrics showed an increase by 63.56%, 116.09%, 118.67%, 104.19%, 80.33% and 119.67%, respectively, in comparison to 1990. In 2019, the disease burden of T2DM in China, after standardized age, was lower than that in the United States and globally. In 2019, Chinese men exhibited a higher burden of T2DM compared to women after standardization. The DALY rate of T2DM increased from 330.67/100 000 in 1990 to 675.18/100 000 in 2019, marking an increase of 104.19%. Conclusions China′s standardized disease burden indicators for T2DM are lower than those of the United States and the world, but these indicators have been following an upward trajectory year after year, both in crude and after standardization. Therefore, China′s efforts to prevent and treat T2DM still need to be further strengthened.
- Type 2 diabetes mellitus,
- Disease burden,
- Morbidity,
- Mortality,
- Disability adjusted life year

FullText(HTML)

References(25)

References

[1]	Lin XL, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025[J]. Sci Rep, 2020, 10(1): 14790. DOI: 10.1038/s41598-020-71908-9.
[2]	中国老年2型糖尿病防治临床指南编写组, 中国老年医学学会老年内分泌代谢分会, 中国老年保健医学研究会老年内分泌与代谢分会, 等. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中华内科杂志, 2022, 61(1): 12-50. DOI: 10.3760/cma.j.cn112138-20211027-00751. Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group; Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society; Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society, et al. Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)[J]. Chin J Inrern Med, 2022, 61(1): 12-50. DOI: 10.3760/cma.j.cn112138-20211027-00751.
[3]	郭立新. 糖尿病的流行势态和应对策略[J]. 中国临床保健杂志, 2020, 23(4): 433-436. DOI: 10.3969/J.issn.1672-6790.2020.04.001. Guo LX. The epidemic situation and intervention strategies of diabetes mellitus[J]. Chin J Clin Healthc, 2020, 23(4): 433-436. DOI: 10.3969/J.issn.1672-6790.2020.04.001.
[4]	Chen H, Chen G, Zheng XY, et al. Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study[J]. BMJ, 2019, 364: l969. DOI: 10.1136/bmj.l969.4.
[5]	李茜瑶, 周莹, 黄辉, 等. 疾病负担研究进展[J]. 中国公共卫生, 2018, 34(5): 777-780. DOI: 10.11847/zgggws1118319. Li XY, Zhou Y, Huang H, et al. Progress in disease burden researches[J]. Chin J Public Health, 2018, 34(5): 777-780. DOI: 10.11847/zgggws1118319.
[6]	邵琦, 吴毅凌, 江峰, 等. 脂质蓄积指数与糖尿病患病风险的关系[J]. 中华疾病控制杂志, 2022, 26(2): 125-130, 243. DOI: 10.16462/j.cnki.zhjbkz.2022.02.001. Shao Q, Wu YL, Jiang F, et al. The relationship between lipid accumulation product and the risk of diabetes[J]. Chin J Dis Control Prev, 2022, 26(2): 125-130, 243. DOI: 10.16462/j.cnki.zhjbkz.2022.02.001.
[7]	Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12): 1090-1101. DOI: 10.1056/NEJMoa0908292.
[8]	Lu JL, He J, Li M, et al. Predictive value of fasting glucose, postload glucose, and hemoglobin A_1c on risk of diabetes and complications in Chinese adults[J]. Diabetes Care, 2019, 42(8): 1539-1548. DOI: 10.2337/dc18-1390.
[9]	Pang SJ, Song PK, Sun XQ, et al. Dietary fructose and risk of metabolic syndrome in Chinese residents aged 45 and above: results from the China National Nutrition and Health Survey[J]. Nutr J, 2021, 20(1): 83. DOI: 10.1186/s12937-021-00739-9.
[10]	Wei J, Liu X, Xue H, et al. Comparisons of visceral adiposity index, body shape index, body mass index and waist circumference and their associations with diabetes mellitus in adults[J]. Nutrients, 2019, 11(7): 1580. DOI: 10.3390/nu11071580.
[11]	Barbiellini Amidei C, Fayosse A, Dumurgier J, et al. Association between age at diabetes onset and subsequent risk of dementia[J]. JAMA, 2021, 325(16): 1640-1649. DOI: 10.1001/jama.2021.4001.
[12]	Dugani SB, Moorthy MV, Li C, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women[J]. JAMA Cardiol, 2021, 6(4): 437-447. DOI: 10.1001/jamacardio.2020.7073.
[13]	Chi MJ, Liang CK, Lee WJ, et al. Association of new-onset diabetes mellitus in older people and mortality in taiwan: A 10-year nationwide population-based Study[J]. J Nutr Health Aging, 2017, 21(2): 227-232. DOI: 10.1007/s12603-016-0751-9.
[14]	Kanasi E, Ayilavarapu S, Jones J. The aging population: demographics and the biology of aging[J]. Periodontol 2000, 2016, 72(1): 13-8. DOI: 10.1111/prd.12126.
[15]	Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus[J]. Endocr Rev, 2016, 37(3): 278-316. DOI: 10.1210/er.2015-1137.
[16]	Mauvais-Jarvis F, Manson JE, Stevenson JC, et al. Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications[J]. Endocr Rev, 2017, 38(3): 173-188. DOI: 10.1210/er.2016-1146.
[17]	Hu C, Jia WP. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication[J]. Diabetes, 2018, 67(1): 3-11. DOI: 10.2337/dbi17-0013.
[18]	Huo XX, Zhang JQ, Guo XH, et al. Gender difference in the sssociation of early- vs. late-onset type 2 diabetes with non-fatal microvascular disease in China: a cross-sectional study[J]. Front Endocrinol (Lausanne), 2018, 9: 15. DOI: 10.3389/fendo.2018.00015.
[19]	Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies[J]. BMJ, 2006, 332(7533): 73-78. DOI: 10.1136/bmj.38678.389583.7C.
[20]	Yang GH, Wang Y, Zeng YX, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013, 381(9882): 1987-2015. DOI: 10.1016/S0140-6736(13)61097-1.
[21]	Meroni G, Valerio A, Vezzoli M, et al. The relationship between air pollution and diabetes: A study on the municipalities of the Metropolitan City of Milan[J]. Diabetes Res Clin Pract, 2021, 174: 108748. DOI: 10.1016/j.diabres.2021.108748.
[22]	Li X, Wang MY, Song YZ, et al. Obesity and the relation between joint exposure to ambient air pollutants and incident type 2 diabetes: a cohort study in UK Biobank[J]. PLoS Med, 2021, 18(8): e1003767. DOI: 10.1371/journal.pmed.1003767.
[23]	Zhao L, Fang JL, Tang S, et al. PM2.5 and serum metabolome and insulin resistance, potential mediation by the gut microbiome: a population-based panel study of older adults in China[J]. Environ Health Perspect, 2022, 130(2): 27007. DOI: 10.1289/EHP9688.
[24]	Xu HB, Liu SC, Wang Y, et al. The mediating role of vascular inflammation in traffic-related air pollution associated changes in insulin resistance in healthy adults[J]. Int J Hyg Environ Health, 2022, 239: 113878. DOI: 10.1016/j.ijheh.2021.113878.
[25]	中华医学会糖尿病分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344. DOI: 10.19538/j.nk2018040108. Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)[J]. Chin J Pract Intern Med, 2018, 38(4): 292-344. DOI: 10.19538/j.nk2018040108.